Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Huasu Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical company specializing in the research, development, and manufacturing of both over-the-counter (OTC) and prescription medications. The company is most famous for its flagship product, Huasu Pian (Cydiodine tablets), which is a leading treatment for oral and throat infections in China. Beyond its oral care portfolio, Beijing Huasu focuses on therapeutic areas such as cardiovascular diseases, central nervous system disorders, and gastrointestinal health. Originally originating from the pharmaceutical factory of the Academy of Military Medical Sciences, the company maintains a strong reputation for quality and clinical efficacy. It operates modern manufacturing facilities that comply with national GMP standards and continues to expand its presence in the domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 北京华素.